Wound exudate as a proteomic window to reveal different mechanisms of tissue damage by snake venom toxins

Journal of Proteome Research

Volumn 8, Issue 11, 2009, Pages 5120-5131

  Escalante, Teresa ^a   Rucavado, Alexandra ^a   Pinto, Antonio F M ^b   Terra, Renata M S ^b   Gutiérrez, José María ^a   Fox, Jay W ^b  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Apolipoproteins; Basement membranes; Extracellular matrix; Myonecrosis; Non fibrillar collagens; Phospholipases A2; Snake venom metalloproteinases; Snake venoms; SVMPs; Wound exudate

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; COLLAGEN TYPE 1; FIBRONECTIN; METALLOPROTEINASE; PHOSPHOLIPASE A2; PROTEOME; SNAKE VENOM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; ENVENOMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; TISSUE INJURY; TOXIN ANALYSIS; WOUND FLUID;

ANIMALS; BOTHROPS; CHROMATOGRAPHY, LIQUID; EXTRACELLULAR MATRIX PROTEINS; EXUDATES AND TRANSUDATES; KERATINS; MASS SPECTROMETRY; METALLOENDOPEPTIDASES; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; PHOSPHOLIPASES A2; PROTEOMICS; SKIN; SNAKE BITES; SNAKE VENOMS; TANDEM MASS SPECTROMETRY; WOUND HEALING;

MUS;

EID: 70449428630     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900489m     Document Type: Article

References (64)

1. Gallin, J. I.; Snyderman, R. Inflammation. Basic Principles and Clinical Correlates; Lippincot: Philadelphia, 1999.
2. Yager, D. R.; Nwomeh, B. C. The proteolytic environment of chronic wounds. Wound Repair Regen. 1999, 7, 433-441.
3. Cutting, K. F. Wound exudate: composition and functions. Br. J. Community Nurs. 2003, 8 (Suppl. 9), 4-9.
4. Fernandez, M. L.; Broadbent, J. A.; Shooter, G. K.; Malda, J.; Upton, Z. Development of an enhanced proteomic method to detect prognostic and diagnostic markers of healing in chronic wound fluid. Br. J. Dermatol. 2008, 158, 281-290.
5. Mast, B. A.; Schultz, G. S. Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 1996, 4, 411-420. (Pubitemid 126670858)
6. Pollins, A. C.; Friedman, D. B.; Nanney, L. B. Proteomic investigation of human burn wounds by 2D-difference gel electrophoresis and mass spectrometry. J. Surg. Res. 2007, 142, 143-152.
7. Conti, A.; Sanchez-Ruiz, Y.; Bachi, A.; Beretta, L.; Grandi, E.; Beltramo, M.; Alessio, M. Proteome study of human cerebrospinal fluid following traumetic brain injury indicates fibrin(ogen) degradation products as traume-associated markers. J. Neurotrauma 2004, 21, 854-863. (Pubitemid 38998913)
8. Sinha, A.; Srivastava, N.; Singh, S.; Singh, A. K.; Bhushan, S.; Shukla, R.; Singh, M. P. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: A proteomic approach. Clin. Chim. Acta 2009, 400, 14-20.
9. Shitama, T.; Hayashi, H.; Noge, S.; Uchio, E.; Oshima, K.; Haniu, H.; Takemori, N.; Komori, N.; Matsumoto, H. Proteome profiling of vitreoretinal diseases by cluster analysis. Proteomics Clin. Appl. 2008, 2, 1265-1280.
10. Kuk, C.; Kulasingam, V.; Gunawardana, C. G.; Smith, C. R.; Batruch, I.; Diamandis, E. P. Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Mol. Cell. Proteomics 2009, 8, 661-669.
11. Lin, W. T.; Tsai, C. C.; Chen, C. Y.; Lee, W. J.; Su, C. C.; Wu, Y. J. Proteomic analysis of peritoneal dialysate fluid in patients with dialysis-related peritonitis. Ren. Fail. 2008, 30, 772-777.
12. Tabushi, Y.; Nakanishi, T.; Takeuchi, T.; Nakajima, M.; Ueda, K.; Kotani, T.; Makino, S.; Shimizu, A.; Hanafusa, T.; Takubo, T. Detection of citrullinated proteins in synovial fluids derived from patients with rheumatoid arthritis by proteomics-based analysis. Ann. Clin. Biochem. 2008, 45, 413-417. (Pubitemid 352031550)
13. Gray, R. D.; MacGregor, G.; Noble, D.; Imrie, M.; Dewar, M.; Boyd, A. C.; Innes, J. A.; Porteous, D. J.; Greening, A. P. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am. J. Resp. Crit. Care Med. 2008, 178, 444-452.
14. Wu, J.; Kobayashi, M.; Sousa, E. A.; Liu, W.; Cai, J.; Goldman, S. J.; Dorner, A. J.; Projan, S. J.; Kavuru, M. S.; Qui, Y.; Thomassen, M. J. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol. Cell. Proteomics 2005, 4, 1251-1264.
15. Zhou, L.; Beuerman, R. W.; Huang, L.; Barathi, A.; Foo, Y. H.; Li, S. F.; Chew, F. T.; Tan, D. Proteomic analysis of rabbit tear fluid: Defensin levels after an experimental corneal wound are correlated with wound closure. Proteomics 2007, 7, 3194-3206. (Pubitemid 47477961)
16. Merrick, B. A.; Bruno, M. E.; Madenspacher, J. H.; Wetmore, B. A.; Foley, J.; Pieper, R.; Zhao, M.; Makusky, A. J.; McGrath, A. M.; Zhou, J. X.; Taylor, J.; Tomer, K. B. Alterations in the rat serum proteome during liver injury from acetaminophen exposure. J. Pharmacol. Exp. Ther. 2006, 318, 792-802.
17. Quian, W. J.; Jacobs, J. M.; Camp, D. G.; Monroe, M. E.; Moore, R. J.; Gritsenko, M. A.; Calvano, S. E.; Lowry, S. F.; Xiao, W.; Moldawer, L. L.; Davis, R. W.; Tompinks, R. G.; Smith, R. D. Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 2005, 5, 572-584.
18. Li, S. J.; Peng, M.; Li, H.; Liu, B. S.; Wang, C.; Wu, J. R.; Li, Y. X.; Zeng, R. Sys-Body Fluid: a systematic database for human body fluid proteome research. Nucleic Acids Res. 2009, 37, D907-D912.
19. Gutiérrez, J. M.; Lomonte, B. Efectos locales en el envenenamiento ofídico en América Latina. In: Animais Peçonhentos no Brasil. Biología, Clínica e Terapêutica dos Acidentes; Cardoso, J. L. C., França, F. O. S., Wen, F. H., Málaque, C. M. S.;, Haddad, V., Eds.; Sarvier: Sao Paulo, 2003; pp 310-323.
20. Otero, R.; Gutiérrez, J.; Mesa, M. B.; Duque, E.; Rodríguez, O.; Arango, J. L.; Gómez, F.; Toro, A.; Cano, F.; Rodríguez, L. M.; Caro, E.; Martínez, J.; Cornejo, W.; Gómez, L. M.; Uribe, F. L.; Cárdenas, S.; Núñez, V.; Díaz, A. Complications of Bothrops, Porthidium and Bothriechis snakebites in Colombia. A clinical and epidemiological study of 39 cases attended in a university hospital. Toxicon 2002, 40, 1107-1114.
21. Warrell, D. A. Epidemiology, clinical features and management of snake bites in Central and South America. In Venomous Reptiles of the Western Hemisphere; Campbell, J., Lamar, W. W., Eds.; Cornell University Press: Ithaca, 2004; pp 709-761.
22. Gutiérrez, J. M.; Theakston, R. D. G.; Warrell, D. A. Confronting the neglected problem of snake bite envenoming: the need for a global partnership. PLoS Med. 2006, 3, e412.
23. Gutiérrez, J. M.; Rucavado, A. Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage. Biochimie 2000, 82, 841-850. (Pubitemid 30843365)
24. Gutiérrez, J. M.; Ownby, C. L. Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity. Toxicon 2003, 42, 915-931. (Pubitemid 38201492)
25. Fox, J. W.; Serrano, S. M. T. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 2005, 45, 969-985.
26. Bjarnason, J. B.; Fox, J. W. Hemorrhagic metalloproteinases from snake venoms. Pharmac. Ther. 1994, 62, 325-372.
27. Gutiérrez, J. M.; Rucavado, A.; Escalante, T.; Díaz, C. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 2005, 45, 997-1011. (Pubitemid 40732576)
28. Rucavado, A.; Núñez, J.; Gutiérrez, J. M. Blister formation and skin damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int. J. Exp. Pathol. 1998, 79, 245-254.
29. Jiménez, N.; Escalante, T.; Gutiérrez, J. M.; Rucavado, A. Skin pathology induced by snake venom metalloproteinase: acute damage, revascularization, and re-epithelization in a mouse ear model. J. Invest. Dermatol. 2008, 128, 2421-2428.
30. Rucavado, A.; Lomonte, B.; Ovadia, M.; Gutiérrez, J. M. Local tissue damage induced by BaP1, a metalloproteinase isolated from Bothrops asper (terciopelo) snake venom. Exp. Mol. Pathol. 1995, 63, 186-199.
31. Gutiérrez, J. M.; Romero, M.; Núñez, J.; Chaves, F.; Borkow, G.; Ovadia, M. Skeletal muscle necrosis and regeneration after injection of BaH1, a hemorrhagic metalloproteinase isolated from the venom of the snake Bothrops asper (terciopelo). Exp. Mol. Pathol. 1995, 62, 28-41.
32. Teixeira, C. F. P.; Fernandes, C. M.; Zuliani, J. P.; Zamuner, S. F. Inflammatory effects of snake venom metalloproteinases. Mem. Inst. Oswaldo Cruz 2005, 100 (Suppl. 1), 181-184. (Pubitemid 40685461)
33. Gallagher, P.; Bao, Y.; Serrano, S. M. T.; Laing, G. D.; Theakston, R. D. G.; Gutiérrez, J. M.; Escalante, T.; Zigrino, P.; Moura-da-Silva, A. M.; Nischt, R.; Mauch, C.; Moskaluk, C.; Fox, J. W. Role of snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin. Arch. Biochem. Biophys. 2005, 441, 1-15.
34. 2 myotoxins and neurotoxins: common aspects of their mechanisms of action. Cell. Mol. Life Sci. 2008, 65, 2897-2912.
35. 2 from Bothrops asper snake venom: pharmacological mediation and molecular determinants. Toxicon 2003, 41, 667-678.
36. Mora, J.; Mora, R.; Lomonte, B.; Gutiérrez, J. M. Effects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomation. PLoS Neglec. Trop. Dis. 2008, 2, e318.
37. Teixeira, C. F. P.; Landucci, E. C. T.; Antunes, E.; Chacur, M.; Cury, Y. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon 2003, 42, 947-962. (Pubitemid 38201494)
38. Gutiérrez, J. M.; Romero, M.; Díaz, C.; Borkow, G.; Ovadia, M. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon 1995, 33, 19-29.
39. Watanabe, L.; Shannon, J. D.; Valente, R. H.; Rucavado, A.; Alape-Girón, A.; Kamiguti, A. S.; Theakston, R. D. G.; Fox, J. W.; Gutiérrez, J. M.; Arni, R. K. Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities. Protein Sci. 2003, 12, 2273-2281.
40. Gutiérrez, J. M.; Ownby, C. L.; Odell, G. V. Isolation of a myotoxin from Bothrops asper venom: Partial characterization and action on skeletal muscle. Toxicon 1984, 22, 115-128. (Pubitemid 14174746)
41. Gutiérrez, J. M.; Ownby, C. L.; Odell, G. V. Pathogenesis of myonecrosis induced by crude venom and a myotoxin of Bothrops asper. Exp. Mol. Pathol. 1984, 40, 367-379. (Pubitemid 14083864)
42. Gutiérrez, J. M.; Lomonte, B.; Chaves, F.; Moreno, E.; Cerdas, L. Pharmacological activities of a toxic phospholipase A isolated from the venom of the snake Bothrops asper. Comp. Biochem. Physiol. 1986, 84, 159-164.
43. Bjorhall, K.; Miliotis, T.; Davidsson, P. Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 2005, 5, 307-317. (Pubitemid 40189661)
44. Boschetti, E.; Righetti, P. G. The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics 2009, 9, 1492-1510
45. 2 isolated from the venom of the snake Bothrops asper (terciopelo). Toxicon 1998, 36, 1861-1869.
46. 2 isolated from Bothrops asper snake venom: role in catalytic activity. Toxicon 2005, 45, 335-346.
47. Fernandes, C. M.; Zamuner, S. R.; Zuliani, J. P.; Rucavado, A.; Gutiérrez, J. M.; Teixeira, C. F. P. Inflammatory effects of BaP1, a metalloproteinase isolated from Bothrops asper snake venom: leukocyte recruitment and release of cytokines. Toxicon 2006, 47, 549-559.
48. 2-dependent mechanisms. Br. J. Pharmacol. 2007, 151, 1254-1261.
49. Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 1999, 340, 448-454. (Pubitemid 29084777)
50. van der Westhuyzen, D. R.; de Beer, F. C.; Webb, N. R. HDL cholesterol transport during inflammation. Curr. Op. Lipidology 2007, 18, 147-151.
51. Jahangiri, A.; de Beer, M. C.; Noffsinger, V.; Tannock, L. R.; Ramaiah, C.; Webb, N. R.; van der Westhuyzen, D. R.; de Beer, F. C. HDL remodeling during the acute phase response. Arterioscler. Thromb. Vasc. Biol 2009, 29, 261-267.
52. Rye, K. A.; Duong, M. N. Influence of phospholipids depletion on the size, structure, and remodeling of reconstituted high density lipoproteins. J. Lipid Res. 2000, 41, 1640-1650.
53. Ownby, C. L.; Geren, C. R. Pathogenesis of hemorrhage induced by hemorrhagic proteinase IV from timber rattlesnake (Crotalus horridus). Toxicon 1987, 25, 517-526.
54. Moreira, L.; Borkow, G.; Ovadia, M.; Gutiérrez, J. M. Pathological changes induced by BaH1, a hemorrhagic metalloproteinase isolated from Bothrops asper (terciopelo) snake venom, on mouse capillary blood vessels. Toxicon 1994, 32, 977-987.
55. Markland, F. S. Snake venoms and the hemostatic system. Toxicon 1998, 36, 1749-1800.
56. Rucavado, A.; Escalante, T.; Teixeira, C. F. P.; Fernandes, C. M.; Díaz, C.; Gutiérrez, J. M. Increments in cytokines and matrix metalloproteinases in skeletal muscle after injection of tissuedamaging toxins from the venom of the snake Bothrops asper. Med. Inflamm. 2002, 11, 121-128.
57. Ohsaka, A. Hemorrhagic, necrotizing and edema-forming effects of snake venoms. In: Handbook of Experimental Pharmacology, Vol.52; Lee, C. Y., Ed.; Springer Verlag: Berlin, 1979; pp 480-546.
58. Baramova, E. N.; Shannon, J. D.; Bjarnason, J. B.; Fox, J. W. Degradation of extracellular matrix proteins by hemorrhagic metalloproteinases. Arch. Biochem. Biophys. 1989, 275, 63-71. (Pubitemid 19280687)
59. Escalante, T.; Shannon, J.; Moura-da-Silva, A. M.; Gutiérrez, J. M.; Fox, J. W. Novel insights into capillary vessel basement membrane damage by snake venom hemorrhagic metalloproteinases: A biochemical and immunohistochemical study. Arch. Biochem. Biophys. 2006, 455, 144-153. (Pubitemid 44708849)
60. Pinto, A. F.; Ma, L.; Dragulev, B.; Guimaraes, J. A.; Fox, J. W. Use of SILAC for exploring sheddase and matrix degradation of fibroblasts in culture by the PIII SVMP atrolysin A: identification of two novel substrates with functional relevance. Arch. Biochem. Biophys. 2007, 465, 11-15.
61. Serrano, S. M. T.; Kim, J.; Wang, D.; Dragulev, B.; Shannon, J. D.; Mann, H. H.; Veit, G.; Wagener, R.; Koch, M.; Fox, J. W. The cysteine-rich domain of snake venom metalloproteinases is a ligand for von Willebrand factor A domains: role in substrate targeting. J. Biol. Chem. 2006, 281, 39746-39756.
62. Jimenez-Mallebrera, C.; Maioli, M. A.; Kim, J.; Brown, S. C.; Feng, L.; Lampe, A. K.; Bushby, K.; Hicks, D.; Flanigan, K. M.; Bonnemann, C.; Sewry, C. A.; Muntoni, F. A comparative analysis of collagen VI production in muscle, skin and fibriblasts from 14 Ullrich congenital muscular dystrophy patients with dominant and recessive COLA6 mutations. Neurom. Disord. 2006, 16, 571-582.
63. Kuo, H. J.; Maslen, C. L.; Keene, D. R.; Glanville, R. W. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J. Biol. Chem. 1997, 42, 26522-26529.
64. Nikitovic, D.; Katonis, P.; Tsatsakis, A.; Karamanos, N. K.; Tsanakakis, G. N. Lumican, a small leucine-rich proteoglycan. IUBMB Life 2008, 60, 818-823.